| Primary |
| Osteoporosis |
57.9% |
| Product Used For Unknown Indication |
12.3% |
| Hypertension |
7.6% |
| Drug Use For Unknown Indication |
4.4% |
| Osteopenia |
3.0% |
| Rheumatoid Arthritis |
2.0% |
| Osteoporosis Postmenopausal |
1.6% |
| Diabetes Mellitus |
1.2% |
| Hypothyroidism |
1.2% |
| Back Pain |
1.0% |
| Dyslipidaemia |
1.0% |
| Osteoarthritis |
1.0% |
| Blood Pressure |
0.8% |
| Coronary Artery Disease |
0.8% |
| Gastritis |
0.8% |
| Pain |
0.8% |
| Arthritis |
0.6% |
| Calcium Deficiency |
0.6% |
| Depression |
0.6% |
| Epilepsy |
0.6% |
|
| Death |
21.6% |
| Vomiting |
9.7% |
| Myocardial Infarction |
7.5% |
| Cardiac Disorder |
5.2% |
| Cerebrovascular Accident |
5.2% |
| Nausea |
5.2% |
| Pain |
4.5% |
| Pyrexia |
4.5% |
| Cardio-respiratory Arrest |
3.7% |
| Hip Fracture |
3.7% |
| Wrist Fracture |
3.7% |
| Malaise |
3.0% |
| Myalgia |
3.0% |
| Osteonecrosis |
3.0% |
| Pneumonia |
3.0% |
| Renal Failure |
3.0% |
| Tooth Extraction |
3.0% |
| Upper Limb Fracture |
3.0% |
| Bone Pain |
2.2% |
| Cardiac Arrest |
2.2% |
|
| Secondary |
| Osteoporosis |
55.0% |
| Osteoarthritis |
5.0% |
| Diabetes Mellitus |
4.0% |
| Hypertension |
4.0% |
| Rheumatoid Arthritis |
4.0% |
| Osteopenia |
3.0% |
| Plasma Cell Myeloma |
3.0% |
| Product Used For Unknown Indication |
3.0% |
| Blood Pressure |
2.0% |
| Breast Cancer Metastatic |
2.0% |
| Essential Hypertension |
2.0% |
| Hypersensitivity |
2.0% |
| Osteoporosis Postmenopausal |
2.0% |
| Osteoporotic Fracture |
2.0% |
| Spondylitis |
2.0% |
| Arthralgia |
1.0% |
| Chondrocalcinosis Pyrophosphate |
1.0% |
| Coronary Artery Disease |
1.0% |
| Dyslipidaemia |
1.0% |
| Extrasystoles |
1.0% |
|
| Impaired Healing |
10.3% |
| Musculoskeletal Pain |
6.9% |
| Nausea |
6.9% |
| Osteonecrosis Of Jaw |
6.9% |
| Pruritus |
6.9% |
| Tooth Extraction |
6.9% |
| Vaginal Haemorrhage |
6.9% |
| Vomiting |
6.9% |
| Bone Density Decreased |
3.4% |
| Death |
3.4% |
| Drug Ineffective |
3.4% |
| Drug Interaction |
3.4% |
| Exposed Bone In Jaw |
3.4% |
| Femur Fracture |
3.4% |
| General Physical Health Deterioration |
3.4% |
| Haematochezia |
3.4% |
| Laryngeal Pain |
3.4% |
| Myocardial Infarction |
3.4% |
| Oedema |
3.4% |
| Pain |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
22.1% |
| Rheumatoid Arthritis |
22.1% |
| Osteoporosis |
17.9% |
| Hypertension |
8.0% |
| Atrial Fibrillation |
4.2% |
| Depression |
3.0% |
| Pain |
3.0% |
| Asthma |
1.9% |
| Hypercholesterolaemia |
1.9% |
| Juvenile Arthritis |
1.9% |
| Schnitzler's Syndrome |
1.9% |
| Arthralgia |
1.5% |
| Diffuse Large B-cell Lymphoma |
1.5% |
| Essential Hypertension |
1.5% |
| Osteopenia |
1.5% |
| Prophylaxis |
1.5% |
| Anxiety |
1.1% |
| Back Pain |
1.1% |
| Cardiac Failure |
1.1% |
| Headache |
1.1% |
|
| Gastroenteritis |
10.0% |
| Death |
6.7% |
| Gastrointestinal Haemorrhage |
6.7% |
| Nausea |
6.7% |
| Pregnancy |
6.7% |
| Respiratory Tract Congestion |
6.7% |
| Urinary Tract Infection |
6.7% |
| Weight Decreased |
6.7% |
| Wrong Technique In Drug Usage Process |
6.7% |
| Atrial Fibrillation |
3.3% |
| Basal Cell Carcinoma |
3.3% |
| Cervical Vertebral Fracture |
3.3% |
| Colon Adenoma |
3.3% |
| Diarrhoea |
3.3% |
| Drug Ineffective |
3.3% |
| Femur Fracture |
3.3% |
| Hepatocellular Injury |
3.3% |
| Hypertransaminasaemia |
3.3% |
| Hypothyroidism |
3.3% |
| Influenza |
3.3% |
|
| Interacting |
| Coronary Artery Disease |
20.0% |
| Dyslipidaemia |
20.0% |
| Extrasystoles |
20.0% |
| Fibrillation |
20.0% |
| Osteoporosis |
20.0% |
|
|
